Virtus LifeSci Biotech Clinical Trls ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit Virtus LifeSci Biotech Clinical Trls ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Summit Therapeutics Inc Ordinary Shares

2.02 222,561
Healthcare

Bny Mellon Cash Reserve Usd

1.93 213,192
Cash and Equivalents

Viridian Therapeutics Inc

1.54 170,017
Healthcare

Longboard Pharmaceuticals Inc

1.53 168,188
Healthcare

IGM Biosciences Inc Ordinary Shares

1.52 167,126
Healthcare

Centessa Pharmaceuticals PLC ADR

1.37 150,974
Healthcare

Applied Therapeutics Inc

1.33 147,026
Healthcare

Vaxcyte Inc Ordinary Shares

1.29 142,127
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

1.27 140,439
Healthcare

Edgewise Therapeutics Inc

1.27 140,253
Healthcare

Sponsor Center